CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Lankinen, Maria A ^a   Hanhineva, Kati ^a   Kolehmainen, Marjukka ^a   Lehtonen, Marko ^a   Auriola, Seppo ^a   Mykkänen, Hannu ^a   Poutanen, Kaisa ^a   Schwab, Ursula ^a,b   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 CARBOXY 4 METHYL 5 PROPYL 2 FURANPROPANOIC ACID; INSULIN; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID; FURAN DERIVATIVE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FISH MEAL; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; ANIMAL; BILBERRY; BLOOD; CHEMISTRY; DIET; DIET RESTRICTION; DIET THERAPY; FISH; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TANDEM MASS SPECTROMETRY;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, LIQUID; DIET; FASTING; FATTY ACIDS, OMEGA-3; FEMALE; FISHES; FURANS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPIONATES; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES; VACCINIUM MYRTILLUS;

EID: 84928966552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124379     Document Type: Article

References (17)

1. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011; 121: 1402-1411. doi: 10.1172/JCI44442 PMID: 21403394
2. Wong G, Barlow CK, Weir JM, Jowett JB, Magliano DJ, Zimmet P, et al. Inclusion of Plasma Lipid Species Improves Classification of Individuals at Risk of Type 2 Diabetes. PLoS One. 2013; 8: e76577. doi: 10.1371/journal.pone.0076577 PMID: 24116121
3. Prentice KJ, Luu L, Allister EM, Liu Y, Jun LS, Sloop KW, et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces beta cell dysfunction. Cell Metab. 2014; 19: 653-666. doi: 10.1016/j.cmet.2014.03.008 PMID: 24703697
4. Spiteller G. Furan fatty acids: occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet? Lipids. 2005; 40: 755-771. PMID: 16296395
5. Vetter W, Wendlinger C. Furan fatty acids-valuable minor fatty acids in food. Lipid Technology. 2013; 25: 7-10.
6. Wahl HG, Tetschner B, Liebich HM. The effect of dietary fish oil supplementation on the concentration of 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human blood and urine. J. High Resolut. Chromatogr. 1992; 15: 815-818.
7. Hanhineva K, Lankinen M, Pedret A, Schwab U, Kolehmainen M, Paananen J, et al. Nontargeted Metabolite Profiling Discriminates Diet-Specific Biomarkers for Concumption of Whole Grains, Fatty Fish, and Bilberries in a Randomized Controlled Trial. Journal of Nutrition. 2015; 145: 1-12. doi: 10.3945/jn.114.194324 PMID: 25355840
8. Patel PS, Sharp SJ, Luben RN, Khaw KT, Bingham SA, Wareham NJ, et al. Association between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study. Diabetes Care. 2009; 32: 1857-1863. doi: 10.2337/dc09-0116 PMID: 19592633
9. Nkondjock A, Receveur O. Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study. Diabetes Metab. 2003; 29: 635-642. PMID: 14707894
10. Rylander C, Sandanger TM, Engeset D, Lund E. Consumption of lean fish reduces the risk of type 2 diabetes mellitus: a prospective population based cohort study of norwegian women. PLoS One. 2014; 9: e89845. doi: 10.1371/journal.pone.0089845 PMID: 24587071
11. Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, Hu FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr. 2009; 90: 613-620. doi: 10.3945/ajcn.2008.27424 PMID: 19625683
12. van Woudenbergh GJ, van Ballegooijen AJ, Kuijsten A, Sijbrands EJ, van Rooij FJ, Geleijnse JM, et al. Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care. 2009; 32: 2021-2026. doi: 10.2337/dc09-1042 PMID: 19675200
13. Zhang M, Picard-Deland E, Marette A. Fish and Marine Omega-3 Polyunsatured Fatty Acid Consumption and Incidence of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2013; 2013: 501015. doi: 10.1155/2013/501015 PMID: 24089611
14. de Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, et al. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia. 2011; 54: 2755-2767. doi: 10.1007/s00125-011-2285-3 PMID: 21870174
15. Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA, et al. A novel UPLC-MSMS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem. 2013; 405: 1937-1947. doi: 10.1007/s00216-012-6636-9 PMID: 23307120
16. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, Mykkänen H, et al. Whole Grain Products, Fish and Bilberries Alter Glucose and Lipid Metabolism in a Randomized, Controlled Trial: The Sysdimet Study. PLoS ONE. 2011; 6: e22646. doi: 10.1371/journal.pone.0022646 PMID: 21901116
17. Niwa T. Removal of protein-bound uraemic toxins by haemodialysis. Blood Purif. 2013; 35 Suppl 2: 20-25. doi: 10.1159/000350843 PMID: 23676831